DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG1B393

Real-time Bid/Ask 03:26:32 2024-06-12 am EDT
209.06 EUR / 210.39 EUR -0.51% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+3.44%
1 month+1.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 210.8 -0.55%
24-06-10 212 -0.08%
24-06-07 212.1 +1.10%
24-06-06 209.8 +0.93%
24-06-05 207.9 -0.15%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 03:01 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG1B39
ISINDE000MG1B393
Date issued 2024-04-02
Maturity 2025-03-21 (283 Days)
Parity 1 : 1
Emission price 213.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 212.4
Lowest since issue 200
Spread 1.33
Spread %0.63%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
234.9 USD
Average target price
278.7 USD
Spread / Average Target
+18.62%
Consensus